Sector GlaxoSmithKline Pharmaceuticals Limited

Aandelen

GLAXO

INE159A01016

Farmaceutische producten

Beurs gesloten - Bombay S.E. 12:00:50 06-07-2026 Variatie 5 dagen Verschil t.o.v. 1 jan (%)
2.400,60 INR +0,33% Intraday-grafiek van GlaxoSmithKline Pharmaceuticals Limited +1,95% -2,85%
Belangrijkste concurrenten
Verschil (%) Varia. 5d. Evolutie 1 maand Evolutie 3 maanden Var. 1 jan Varia. 1j. Varia. 3j. Varia. 5j. Varia. 10j. Kap.($)
+0,33%+1,95%+9,94%+2,30%-2,85%-26,85%+69,50%+58,58%+36,71% 4,26 mld.
-0,59%-2,37%+4,50%+29,53%+11,74%+55,37%+159,24%+410,07%+1.400,64% 1.082 mld.
-1,60%-0,10%+11,23%+7,17%+24,78%+66,32%+59,80%+53,74%+110,57% 633 mld.
-1,59%+0,80%+14,92%+24,03%+12,20%+36,63%+86,78%+121,51%+304,54% 461 mld.
-2,48%+1,37%+4,13%+7,11%+3,78%+31,00%+23,05%-2,78%+34,89% 338 mld.
-2,75%-1,85%+1,73%-6,18%+1,77%+37,35%+35,88%+60,92%+208,27% 299 mld.
-1,91%-0,81%+6,68%+4,49%+14,22%+28,25%+42,79%+48,05%+57,26% 291 mld.
-10,29%+1,64%+17,67%+36,13%-1,60%-27,46%-40,85%+20,05%+78,25% 222 mld.
-2,82%+0,41%+4,71%+5,68%+10,61%+23,58%+62,36%+48,59%+132,00% 202 mld.
-1,85%+1,44%+0,04%-8,55%+4,41%+14,65%+68,09%+87,33%+49,49% 163 mld.
-2,57%-3,02%-7,75%-15,07%-5,08%-6,36%-33,67%-39,84%-34,09% 139 mld.
-1,46%+3,85%+17,14%+19,47%+14,45%+12,94%+50,07%+159,37%+478,71% 134 mld.
-2,27%-3,29%+1,92%-4,54%+5,00%+21,82%-10,73%-15,03%-23,32% 119 mld.
-1,71%-0,28%+3,19%-5,82%+8,19%+41,45%+47,67%+10,11%-4,41% 107 mld.
-1,37%-0,95%-2,47%-7,12%-9,60%-9,29%-21,31%-13,82%+1,45% 104 mld.
-1,32%-0,44%+1,02%-14,94%-8,52%+5,62%+94,31%+76,27%+517,27% 77,98 mld.
-.--%+1,73% - - - - - - - 63,66 mld.
-2,87%+12,80%+45,47%+32,21%+40,29%+98,55%+6,79%+2,45%-41,18% 59,97 mld.
+1,79%+11,88%+15,65%-3,42%-8,59%+2,23%+10,69%-13,50%+261,88% 53,01 mld.
+2,95%+6,59%+9,25%-4,12%+14,11%+25,05%+22,79%+49,19%+25,84% 52,5 mld.
Gemiddelde -1,30%+4,40%+8,37%+5,18%+6,80%+22,68%+38,59%+59,01%+189,20% 230,32 mld.
Gewogen gemiddelde per kap. -1,54%+5,25%+7,33%+12,37%+10,17%+36,18%+68,11%+135,53%+435,68%
Farmaceutische producten - Andere
  1. Beurs
  2. Aandelen
  3. Koers GLAXO
  4. Sector GlaxoSmithKline Pharmaceuticals Limited